Bellevue Group »

Si-bone shares owned by Bellevue Group

Quarter-by-quarter ownership of Si-bone (SIBN) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Si-bone

Tip: Access up to 7 years of quarterly data

All positions including Si-bone held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Si-bone by Bellevue Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6M 125k 20.99

More positions owned by Bellevue Group

Ionis Pharmaceuticals (IONS)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
Vertex Pharmaceuticals Incorporated (VRTX)
Intuitive Surgical Com New (ISRG)
Intra Cellular Therapies (ITCI)
Moderna (MRNA)
Boston Scientific Corporation (BSX)
Alnylam Pharmaceuticals (ALNY)
Abbott Laboratories (ABT)
Revolution Medicines (RVMD)
Stryker Corporation (SYK)
Incyte Corporation (INCY)
Axonics Modulation Technolog (AXNX)
Dex (DXCM)

View all positions for Bellevue Group

Top funds holding Si-bone

Brown Advisory Holdings Incorporated
First Light Asset Management
Vanguard Group
OrbiMed Advisors
Millennium Management
Wellington Management Company
Holocene Advisors
Dimensional Fund Advisors
Impax Asset Management Group
Kent Lake Capital
Soleus Capital Management
Marshall Wace
Victory Capital Management
Charles Schwab Investment Management
Two Sigma Advisers

View all funds holding Si-bone